Identification of Ligand-specific G Protein-coupled Receptor States and Prediction of Downstream Efficacy Via Data-driven Modeling

Overview

Journal Elife

Specialty Biology

Date 2021 Jan 28

PMID 33506760

Citations 24

Authors

Oliver Fleetwood

Jens Carlsson

Lucie Delemotte

Affiliations

Soon will be listed here.

Abstract

Ligand binding stabilizes different G protein-coupled receptor states via a complex allosteric process that is not completely understood. Here, we have derived free energy landscapes describing activation of the β adrenergic receptor bound to ligands with different efficacy profiles using enhanced sampling molecular dynamics simulations. These reveal shifts toward active-like states at the Gprotein-binding site for receptors bound to partial and full agonists, and that the ligands modulate the conformational ensemble of the receptor by tuning protein microswitches. We indeed find an excellent correlation between the conformation of the microswitches close to the ligand binding site and in the transmembrane region and experimentally reported cyclic adenosine monophosphate signaling responses. Dimensionality reduction further reveals the similarity between the unique conformational states induced by different ligands, and examining the output of classifiers highlights two distant hotspots governing agonism on transmembrane helices 5 and 7.

Citing Articles

Targeting serotonin receptors with phytochemicals - an in-silico study.

Elalouf A, Rosenfeld A, Maoz H Sci Rep. 2024; 14(1):30307.

PMID: 39638796 PMC: 11621125. DOI: 10.1038/s41598-024-76329-6.

Dynamic Mechanism for Subtype Selectivity of Endocannabinoids.

Dutta S, Zhao L, Shukla D bioRxiv. 2024; .

PMID: 39554065 PMC: 11565827. DOI: 10.1101/2024.10.25.620304.

Cyclopamine modulates smoothened receptor activity in a binding position dependent manner.

Kim K, Bansal P, Shukla D Commun Biol. 2024; 7(1):1207.

PMID: 39342033 PMC: 11438977. DOI: 10.1038/s42003-024-06906-y.

Mechanistic insights into G-protein coupling with an agonist-bound G-protein-coupled receptor.

Batebi H, Perez-Hernandez G, Rahman S, Lan B, Kamprad A, Shi M Nat Struct Mol Biol. 2024; 31(11):1692-1701.

PMID: 38867113 DOI: 10.1038/s41594-024-01334-2.

The full spectrum of SLC22 OCT1 mutations illuminates the bridge between drug transporter biophysics and pharmacogenomics.

Yee S, Macdonald C, Mitrovic D, Zhou X, Koleske M, Yang J Mol Cell. 2024; 84(10):1932-1947.e10.

PMID: 38703769 PMC: 11382353. DOI: 10.1016/j.molcel.2024.04.008.

References

Harpole T, Delemotte L . Conformational landscapes of membrane proteins delineated by enhanced sampling molecular dynamics simulations. Biochim Biophys Acta Biomembr. 2017; 1860(4):909-926. DOI: 10.1016/j.bbamem.2017.10.033. View

Latorraca N, Venkatakrishnan A, Dror R . GPCR Dynamics: Structures in Motion. Chem Rev. 2016; 117(1):139-155. DOI: 10.1021/acs.chemrev.6b00177. View

Matricon P, Ranganathan A, Warnick E, Gao Z, Rudling A, Lambertucci C . Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A adenosine receptor binding site. Sci Rep. 2017; 7(1):6398. PMC: 5526870. DOI: 10.1038/s41598-017-04905-0. View

Rasmussen S, DeVree B, Zou Y, Kruse A, Chung K, Kobilka T . Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature. 2011; 477(7366):549-55. PMC: 3184188. DOI: 10.1038/nature10361. View

Rasmussen S, Choi H, Fung J, Pardon E, Casarosa P, Chae P . Structure of a nanobody-stabilized active state of the β(2) adrenoceptor. Nature. 2011; 469(7329):175-80. PMC: 3058308. DOI: 10.1038/nature09648. View

Hanson M, Cherezov V, Griffith M, Roth C, Jaakola V, Chien E . A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure. 2008; 16(6):897-905. PMC: 2601552. DOI: 10.1016/j.str.2008.05.001. View

Sencanski M, Glisic S, Snajder M, Veljkovic N, Poklar Ulrih N, Mavri J . Computational design and characterization of nanobody-derived peptides that stabilize the active conformation of the β-adrenergic receptor (β-AR). Sci Rep. 2019; 9(1):16555. PMC: 6851183. DOI: 10.1038/s41598-019-52934-8. View

Harrigan M, Sultan M, Hernandez C, Husic B, Eastman P, Schwantes C . MSMBuilder: Statistical Models for Biomolecular Dynamics. Biophys J. 2017; 112(1):10-15. PMC: 5232355. DOI: 10.1016/j.bpj.2016.10.042. View

Cournia Z, Allen B, Sherman W . Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations. J Chem Inf Model. 2017; 57(12):2911-2937. DOI: 10.1021/acs.jcim.7b00564. View

10.

Klauda J, Venable R, Freites J, OConnor J, Tobias D, Mondragon-Ramirez C . Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J Phys Chem B. 2010; 114(23):7830-43. PMC: 2922408. DOI: 10.1021/jp101759q. View

11.

Masureel M, Zou Y, Picard L, Van Der Westhuizen E, Mahoney J, Rodrigues J . Structural insights into binding specificity, efficacy and bias of a βAR partial agonist. Nat Chem Biol. 2018; 14(11):1059-1066. PMC: 6197491. DOI: 10.1038/s41589-018-0145-x. View

12.

Picard L, Schonegge A, Bouvier M . Structural Insight into G Protein-Coupled Receptor Signaling Efficacy and Bias between Gs and β-Arrestin. ACS Pharmacol Transl Sci. 2020; 2(3):148-154. PMC: 7088954. DOI: 10.1021/acsptsci.9b00012. View

13.

Lamichhane R, Liu J, White K, Katritch V, Stevens R, Wuthrich K . Biased Signaling of the G-Protein-Coupled Receptor βAR Is Governed by Conformational Exchange Kinetics. Structure. 2020; 28(3):371-377.e3. PMC: 7213800. DOI: 10.1016/j.str.2020.01.001. View

14.

Chen K, Keri D, Barth P . Computational design of G Protein-Coupled Receptor allosteric signal transductions. Nat Chem Biol. 2019; 16(1):77-86. DOI: 10.1038/s41589-019-0407-2. View

15.

Liu X, Kaindl J, Korczynska M, Stossel A, Dengler D, Stanek M . An allosteric modulator binds to a conformational hub in the β adrenergic receptor. Nat Chem Biol. 2020; 16(7):749-755. PMC: 7816728. DOI: 10.1038/s41589-020-0549-2. View

16.

Dror R, Arlow D, Borhani D, Jensen M, Piana S, Shaw D . Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations. Proc Natl Acad Sci U S A. 2009; 106(12):4689-94. PMC: 2650503. DOI: 10.1073/pnas.0811065106. View

17.

Staus D, Wingler L, Choi M, Pani B, Manglik A, Kruse A . Sortase ligation enables homogeneous GPCR phosphorylation to reveal diversity in β-arrestin coupling. Proc Natl Acad Sci U S A. 2018; 115(15):3834-3839. PMC: 5899476. DOI: 10.1073/pnas.1722336115. View

18.

Niesen M, Bhattacharya S, Vaidehi N . The role of conformational ensembles in ligand recognition in G-protein coupled receptors. J Am Chem Soc. 2011; 133(33):13197-204. DOI: 10.1021/ja205313h. View

19.

Nygaard R, Zou Y, Dror R, Mildorf T, Arlow D, Manglik A . The dynamic process of β(2)-adrenergic receptor activation. Cell. 2013; 152(3):532-42. PMC: 3586676. DOI: 10.1016/j.cell.2013.01.008. View

20.

Wacker D, Fenalti G, Brown M, Katritch V, Abagyan R, Cherezov V . Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. J Am Chem Soc. 2010; 132(33):11443-5. PMC: 2923663. DOI: 10.1021/ja105108q. View